Concepedia
Statistics
Publications
7
Citations
401
H-Index
Active since
2004
Affiliations
Sentinel Oncology (United Kingdom)(Current)
University of Cambridge
Institute of Cancer Research
Cancer Research UK
Robert G. Boyle is an author at Sentinel Oncology (United Kingdom) specializing in pharmacology, life sciences, and medicinal chemistry.
Publications per year
2004–2017
Identification of Inhibitors of Protein Kinase B Using Fragment-Based Lead Discovery
Gordon Saxty, Steven J. Woodhead, Valério Berdini et al. · Journal of Medicinal Chemistry · 2007 · 139 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +17
Rapid Evolution of 6-Phenylpurine Inhibitors of Protein Kinase B through Structure-Based Design
Alastair Donald, Tatiana McHardy, Martin Rowlands et al. · Journal of Medicinal Chemistry · 2007 · 65 citations · Full text
CHK1 Inhibition Synergizes with Gemcitabine Initially by Destabilizing the DNA Replication Apparatus
Siang‐Boon Koh, Aurélie Courtin, Richard J. Boyce et al. · Cancer Research · 2015 · 62 citations · Full text
Life Sciences, Oncology, Pharmacology +17
Targeting Translation Control with p70 S6 Kinase 1 Inhibitors to Reverse Phenotypes in Fragile X Syndrome Mice
Aditi Bhattacharya, Maggie Mamcarz, Caitlin Mullins et al. · Neuropsychopharmacology · 2015 · 53 citations · Full text
Life Sciences, Molecular Biology, Molecular Genetics +15
The design of a new potent and selective ligand for the orphan bombesin receptor subtype 3 (BRS3)
Robert G. Boyle, John Eric Humphries, T. Andrew Mitchell et al. · Journal of Peptide Science · 2004 · 28 citations
Pharmacy, Medicinal Chemistry, Pharmacology +15
1–5 of 7